News
Keep up to date on information that affects you
11.12.19
Urgent: Sanofi is initiating a voluntary recall of all batches within expiry of Regular Strength Zantac® 75, Maximum Strength Zantac® 150, Maximum Strength Zantac® 150 Cool Mint Tablets
Urgent: Sanofi is initiating a voluntary recall of all batches within expiry of Regular Strength Zantac® 75, Maximum Strength Zantac® 150, Maximum Strength Zantac® 150 Cool Mint Tablets. 
Read more >
11.06.19  Urgent: Grifols Therapeutics issues voluntary market withdrawal of one lot of Gamunex®-C 10%
Grifols Therapeutics is initiating a voluntary market withdrawal of one lot of Gamunex-C
10%. The affected lot information is provided within this notice. 
Read more >
10.04.19  Important: Magnevist® (gadopentetate dimeglumine) injection is no longer FDA-approved in the U.S. marketplace and is being withdrawn at the wholesale level
Magnevist® (gadopentetate dimeglumine) will no longer be available in the U.S. marketplace. 
Read more >
10.02.19  Urgent: Eli Lilly and Company Issues a Voluntary Market Withdrawal of All In-Date Lots of Lartruvo (olaratumab)
Eli Lilly and Company is initiating a voluntary market withdrawal of all in-date lots of Lartruvo (olaratumab) 500mg/50 ml x 1 vial and 190 mg/19 ml x 1 vial. The full notice includes the affected lot information.
Read more >
07.22.19  Urgent: Bayer Issues a Voluntary Recall of Two Lots of Kogenate FS antihemophilic factor (recombinant) 2000 IU
Bayer is initiating a voluntary recall of two lots of Kogenate FS antihemophilic factor (recombinant) 2000 IU. The affected lot information is provided in the full notice.
Read more >
07.05.19  Urgent: Molded Products, Inc. Issues a Voluntary Recall on Medical Device
Molded Products, Inc. is initiating a voluntary medical device recall of the MPC Luer Lock Set. The affected lot information is provided in the full notice.
Read more >
Displaying results 1-5 (of 25)
 |<  < 1 - 2 - 3 - 4 - 5  >  >|